The Mobility Monitor Assessment System is an integrated computer system that can precisely track, assess and archive movement data. The MMAS is portable, user friendly, needs only a 12' x 12' area for testing and is affordable to health-care providers. It will bridge the gap between highly subjective measurements and costly stationary systems.
2. Cost of Falls in Elderly ($Billions)
250
200
150
100
50
0
Present
2040
The cost per fall on average is $19,440.
25% of patients that are hospitalized due to falls never
return to independent living.
Reliable, affordable assessment tools to reduce the risk of
falls do not exist in the market today.
Problem
3. Early
detection to
allow for
intervention
Reduced
Risk of
Falls
Measure
progress over
time
Huge Cost
Savings
Solution: Mobility Monitor
4. Mobility Monitor (MMAS)
State-of-the-art technology that will bridge
the gap between highly subjective
measurements and costly stationary systems.
Description
A breakthrough tool
Economical
Portable
Highly accurate
5.
A non-invasive computer system
that tracks, assesses and
archives movement data –
without the use of markers!
Greatly improves the validity of
testing by replacing subjective
observations with quantitative
measurements.
Technology Overview
6. SENIOR CITIZENS
Therapy
Baseline falls risk assessment
Person with a history of falls;
requires falls risk assessment
PHYSICAL THERAPIST
Evaluates with the assistance
of the MMAS™
PHYSICAL THERAPIST
PHYSICAL THERAPIST
Provides appropriate
therapy as per plan of care
Develops customized plan
of care
PHYSICIAN
Reviews MMAS™ results
and plan of care. Signs off.
Process Overview
8. TYPE OF FACILITIES
NUMBER OF FACILITIES
Physical Therapy
106,000
Occupational Therapy
29,000
Hospital-based rehab
15,000
Free standing rehab
12,000
TOTAL
1% market penetration
162,000
1,620 units @ $8,000/unit
Annual sales at 1%
penetration
Target Market Size
$12,960,000
9. Initial focus on fall risk in the elderly
Other targeted markets:
Telemedicine
Concussion Assessment
Early Detection of Alzheimer’s
Potential Markets
11. Judith Reinhold, RN, Co-Founder & President
Registered Nurse in the State of Illinois. Judith has an extensive medical
background with ten years experience owning and operating a company.
Ralph Reinhold, D.Sc., Co-Founder & Dir. of Science & Innovation
Bachelor’s Degree in Physics from the University of Wisconsin; Masters and
Doctoral Degrees in Optical Sciences & Sensors from the Southeastern Institute
of Technology. Ralph has over 30 years of experience in embedded systems
image processing, systems engineering and optical design.
Wendy Kjeldbjerg, Controller & Project Manager
Masters Degree in Industrial Psychology from Central Michigan. Over 20 years
experience in business and financial management.
Serra Ventures, LLC, Professional Advisory Firm
Tim Hoerr and Dennis Beard, Principals. Seasoned business executives with over
60 combined years of experience. Have invested in 24 high tech enterprises and
consulted with numerous companies.
Leadership Team
12.
Jack Winters, Ph.D., Biomechanical Engineer Marquette
University
Danille Parker, P.T., D.P.T., G.C.S., C.E.E.A.A., Clinical Assistant
Professor, Marquette University
James W. Bacus, Ph.D., Commercialization and Business
Consultant.
Roger O. Smith, Ph.D., OT, Director of Rehabilitation Research
and Design and Disability Center at University of WisconsinMilwaukee
Kate Brewer, PT, MBA, President of Greenfield Rehabilitation
Agency, Inc.
Advisory Team
13. Kaliber
Imaging’s
MMAS
Tinetti/Berg
(subjective)
Vicon Motion
Analysis System
Motion Analysis
Corporation
Products
Objective Data
Yes
No
Yes
Yes
Portable
Yes
Yes
No
No
User-Friendly
Interface
Yes
Yes
No
No
Purchase Price
<$10,000
n/a
$150,000 $400,000
$50,000 $150,000
End-User Cost
$250
n/a
$1,500 - $2,000
$1,500 - $2,000
Non-Invasive
(markerless)
Yes
Yes
No
No
Competitive Advantage
14. Intellectual Property
A patent with multiple claims, covering the key elements of the
MMAS, was filed in 2012
First office action now in process
Medicare Reimbursement
Management is confident that MMAS will be covered under
existing Medicare CPT codes for “falls risk”
New CPT code should not be required to obtain Medicare
approval
Kaliber has engaged with Medicare consultants to assist in
validating these underlying assumptions
IP Status & Medicare Reimb.
15.
Awarded a National Science Foundation (NSF) Phase I SBIR
grant in 2012 -- $150,000.
Awarded NSF Phase II grant -- $480,000 in funding. Contract
scheduled started Oct, 2013.
Planning to submit a Phase I SBIR grant application to the
National Institutes of Health in Apr, 2014 -- $200,000.
Grant Funding
16. Founder
• Company was capitalized with a significant contribution
from the co-founders, approximately $300,000.
Capital
Prototype
Feasibility
Study
Market
Study
• A functional alpha prototype of the MMAS has been
developed.
• A product feasibility report for the MMAS was obtained
from Wisconsin Innovation Service Center, with
encouraging findings that validated the market demand.
• A customer assessment and market study was prepared by
the University of Wisconsin, Nicholas Center.
Strategic Milestones Accomplished
17. Design
Experts
Engaged
Strategy
Experts
Engaged
Advisory
Board
Assembled
Grant
Funding
• Optimal Design has been engaged to provide professional
design and prototyping assistance.
• Serra Ventures engaged to provide strategy and
fundraising expertise.
• The company has assembled a notable set of professional
advisors, including scientific, academic and business
professionals.
• Kaliber has been successful with a NSF Phase I. NSF Phase
II started in Oct, 2013. Other grants applied for.
Strategic Milestones Accomplished
18.
Seeking $650,000 in Seed Funding:
Strategic hires
Beta prototype development
Summary
Strong Team
Complemented
By Exceptional
Advisors
Funding
Cost-Effective,
Breakthrough
Technology in
Prototype
Form
Team
Technology
Market
Large and
Growing
Market
Opportunity
Non-dilutive
Grant Funding